Eyal C. Attar

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

Benjamin L. Ebert, Jennifer Pretz, Jocelyn Bosco et al. · Nature · 2008 · 914 citations · Full text

Life Sciences, Genetics, Molecular Genetics +6

Eprenetapopt (APR-246) and Azacitidine in <i>TP53</i>-Mutant Myelodysplastic Syndromes

David A. Sallman, Amy E. DeZern, Guillermo Garcia‐Manero et al. · Journal of Clinical Oncology · 2021 · 460 citations · Full text

Medicine, Oncology, Pharmacology +5

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

Gail J. Roboz, Courtney D. DiNardo, Eytan M. Stein et al. · Blood · 2019 · 375 citations · Full text

Medicine, Hematology, Pharmacology +12

Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib

Eytan M. Stein, Courtney D. DiNardo, Amir T. Fathi et al. · Blood · 2018 · 329 citations · Full text

Medicine, Hematology, Oncology +13